Atea ASA - Company Profile
Powered by 
All the data and insights you need on Atea ASA in one report.
$295
- Save hours of research time and resources with
our up-to-date Atea ASA Strategy Report
- Understand Atea ASA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Atea ASA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| RU2019127284A | Application | ГЕМИСУЛЬФАТНАЯ СОЛЬ НУКЛЕОТИДА ДЛЯ ЛЕЧЕНИЯ ВИРУСА ГЕПАТИТА С | A61K31/7076; A61K31/708; A61K45/06; A61K9/20; A61K9/2054; A61P31/14; C07B2200/13; C07H19/20 | March 02, 2021 |
| RU2019109263A | Application | 2'-ЗАМЕЩЕННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ РНК-ВИРУСОМ ЗАБОЛЕВАНИЙ | A61K31/675; A61K31/7076; A61P1/00; A61P31/14; C07H19/16; C07H19/20; C07H19/207; C07H23/00; Y02A50/30 | October 08, 2020 |
| EA201991810A1 | Application | ГЕМИСУЛЬФАТНАЯ СОЛЬ НУКЛЕОТИДА ДЛЯ ЛЕЧЕНИЯ ВИРУСА ГЕПАТИТА С | A61K31/7076; C07H19/20; A61K45/06; A61P31/14; A61K9/20; A61K9/2054; A61K31/708; C07B2200/13 | January 09, 2020 |
| EA201791903A1 | Application | β-D-2'-ДЕЗОКСИ-2'-α-ФТОР-2'-β-C-ЗАМЕЩЕННЫЕ-2-МОДИФИЦИРОВАННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ HCV ЗАБОЛЕВАНИЙ | A61K31/7076; A61P31/14; C07H19/16; C07H19/20; C07H19/207 | January 31, 2018 |
| US8108177B2 | Grant | Hang timer for determining time of flight of an object | A63B2024/0025; A63B2069/185; A63B2220/40; A63B2220/836; A63B24/0021; G04F8/08 | January 31, 2012 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer